Literature DB >> 3343004

Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery.

B R Davidson1, J P Neoptolemos, D L Carr-Locke.   

Abstract

Endoscopic sphincterotomy (ES) was attempted in 106 patients with common bile duct (CBD) calculi and gall bladders present, who were considered unfit for surgery on the grounds of age and frailty alone (35%) and/or the presence of major medical problems (65%). Endoscopic sphincterotomy was successful in 105 patients (99%). Early ES related complications occurred in 21 patients (19.8%). Twelve hospital deaths occurred (11.3%), although this was due to biliary causes in only five (4.7%) and one of these was moribund on admission. Complications were more frequent in those in whom initial ES did not clear the common bile duct (30.4%) compared with those in whom this was (11.7%; p = 0.0164). The mortality was also greater in patients in whom there was no ERCP proof of CBD clearance (p = 0.01) unless operated upon. Twelve patients developed gall bladder complications (11.3%) including five with empyema (4.7%). Analysis of clinical, haematological, and biochemical factors together with ERCP findings showed that the only factor which had any value in predicting gall bladder complications was pre-existing cholangitis. The present series was compared with another using ES as a definitive procedure, and with a surgical series. Although there were significant differences in outcome, differences with respect to medical risk factors and the incidence of complications of CBD stones (jaundice, cholangitis, and acute pancreatitis) were striking. Further analysis of these factors may allow a clearer definition of patients most likely to benefit from either ES or surgery.

Entities:  

Mesh:

Year:  1988        PMID: 3343004      PMCID: PMC1433280          DOI: 10.1136/gut.29.1.114

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Mortality following cholecystectomy.

Authors:  M H Seltzer; E Steiger; F E Rosato
Journal:  Surg Gynecol Obstet       Date:  1970-01

2.  Non-operative removal of bile duct stones by duodenoscopic sphincterotomy in the elderly.

Authors:  A S Mee; A G Vallon; J R Croker; P B Cotton
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-22

3.  British experience with duodenoscopic sphincterotomy for removal of bile duct stones.

Authors:  P B Cotton; A G Vallon
Journal:  Br J Surg       Date:  1981-06       Impact factor: 6.939

4.  Exploration of the common bile duct--the relevance of the clinical picture and the importance of peroperative cholangiography.

Authors:  B Cranley; H Logan
Journal:  Br J Surg       Date:  1980-12       Impact factor: 6.939

5.  The timing of cholecystectomy in patients with gallstone pancreatitis. A retrospective analysis of 89 patients.

Authors:  J Elfström
Journal:  Acta Chir Scand       Date:  1978

6.  Factors affecting mortality in biliary tract surgery.

Authors:  H A Pitt; J L Cameron; R G Postier; T R Gadacz
Journal:  Am J Surg       Date:  1981-01       Impact factor: 2.565

7.  Endoscopic treatment of biliary-tract diseases. An international study.

Authors:  L Safrany
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

8.  Duodenoscopic sphincterotomy for removal of bile duct stones in patients with gallbladders.

Authors:  P B Cotton; A G Vallon
Journal:  Surgery       Date:  1982-06       Impact factor: 3.982

9.  Ultrasonically guided percutaneous catheter drainage for gallbladder empyema.

Authors:  R W Radder
Journal:  Diagn Imaging       Date:  1980

10.  Exploration of the common bile duct: a comparative study.

Authors:  K D Vellacott; P H Powell
Journal:  Br J Surg       Date:  1979-06       Impact factor: 6.939

View more
  43 in total

1.  Endoscopic retreatment of recurrent choledocholithiasis after sphincterotomy.

Authors:  M Sugiyama; Y Suzuki; N Abe; T Masaki; T Mori; Y Atomi
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

Review 2.  Endoscopic removal of common duct stones: current indications and controversies.

Authors:  R C Horton; A Lauri; J S Dooley
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

3.  Choledocholithiasis. Endoscopic sphincterotomy or common bile duct exploration.

Authors:  S C Stain; H Cohen; M Tsuishoysha; A J Donovan
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

4.  Risk factors of acute cholecystitis after endoscopic common bile duct stone removal.

Authors:  Jun Kyu Lee; Ji Kon Ryu; Joo Kyung Park; Won Jae Yoon; Sang Hyub Lee; Kwang Hyuck Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

5.  Timing of cholecystectomy for biliary pancreatitis: do the data support current guidelines?

Authors:  Kaori Ito; Hiromichi Ito; Edward E Whang
Journal:  J Gastrointest Surg       Date:  2008-07-18       Impact factor: 3.452

6.  Endoscopic sphincterotomy permits interval laparoscopic cholecystectomy in patients with moderately severe gallstone pancreatitis.

Authors:  T Ryan Heider; Alphonso Brown; Ian S Grimm; Kevin E Behrns
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.452

7.  Case-control comparison of laparoscopic versus open distal pancreatectomy.

Authors:  Vic Velanovich
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.452

8.  Retained common bile duct stones after endoscopic sphincterotomy: temporary and longterm treatment with biliary stenting.

Authors:  D G Maxton; D E Tweedle; D F Martin
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  Common bile duct stenting for choledocholithiasis: a district general hospital experience.

Authors:  D J Bowrey; L J Fligelstone; A Solomon; G Thomas; A A Shandall
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

10.  Prospective validation study of an algorithm for triage to MRCP or ERCP for investigation of suspected pancreatico-biliary disease.

Authors:  C N Parnaby; J T Jenkins; J C Ferguson; B W A Williamson
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.